{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:08:41Z","timestamp":1790431721731,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFF1100100"],"award-info":[{"award-number":["2022YFF1100100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFF1100100"],"award-info":[{"award-number":["2022YFF1100100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFF1100100"],"award-info":[{"award-number":["2022YFF1100100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr J"],"DOI":"10.1186\/s12937-025-01124-6","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T15:28:34Z","timestamp":1751902114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of supplementing Limosilactobacillus fermentum MN\u2013LF23 on the eradication of Helicobacter pylori with 14\u2013day standard quadruple therapy: a randomized, double\u2013blind, placebo\u2013controlled trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuyang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuejian","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"issue":"2","key":"1124_CR1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","volume":"153","author":"JKY Hooi","year":"2017","unstructured":"Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of Helicobacter pylori infection: systematic review and Meta-Analysis [J]. Gastroenterology. 2017;153(2):420\u20139.","journal-title":"Gastroenterology"},{"issue":"3","key":"1124_CR2","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/jgh.15751","volume":"37","author":"S Ren","year":"2022","unstructured":"Ren S, Cai P, Liu Y, et al. Prevalence of Helicobacter pylori infection in China: A systematic review and meta-analysis [J]. J Gastroenterol Hepatol. 2022;37(3):464\u201370.","journal-title":"J Gastroenterol Hepatol"},{"key":"1124_CR3","first-page":"7","volume":"57","author":"IARC working group on the evaluatio","year":"1993","unstructured":"IARC working group on the evaluation of carcinogenic risks to humans. Occupational exposures of hairdressers and barbers and personal use of hair colourants; some hair dyes, cosmetic colourants, industrial dyestuffs and aromatic amines. IARC Monogr Eval Carcinog Risks Hum. 1993;57:7\u2013398. Proceedings. Lyon, France, 6\u201313 October 1992 [J].","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"1124_CR4","doi-asserted-by":"crossref","unstructured":"Yang H, Hu B. Immunological Perspective: Helicobacter pylori Infection and Gastritis [J]. Mediators Inflamm, 2022, 2022: 2944156.","DOI":"10.1155\/2022\/2944156"},{"issue":"12","key":"1124_CR5","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1136\/gutjnl-2020-322368","volume":"69","author":"JM Liou","year":"2020","unstructured":"Liou JM, Malfertheiner P, Lee YC, et al. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus [J]. Gut. 2020;69(12):2093\u2013112.","journal-title":"Gut"},{"key":"1124_CR6","doi-asserted-by":"crossref","unstructured":"Malfertheiner P, Megraud F, Rokkas T et al. Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report [J]. Gut, 2022.","DOI":"10.1136\/gutjnl-2022-327745"},{"issue":"5","key":"1124_CR7","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","volume":"155","author":"A Savoldi","year":"2018","unstructured":"Savoldi A, Carrara E, Graham DY, et al. Prevalence of antibiotic resistance in Helicobacter pylori: A systematic review and Meta-analysis in world health organization regions [J]. Gastroenterology. 2018;155(5):1372\u2013e8217.","journal-title":"Gastroenterology"},{"issue":"4","key":"1124_CR8","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/apt.13497","volume":"43","author":"I Thung","year":"2016","unstructured":"Thung I, Aramin H, Vavinskaya V, et al. Review Article: the global emergence of Helicobacter pylori antibiotic resistance [J]. Aliment Pharmacol Ther. 2016;43(4):514\u201333.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"1124_CR9","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S1473-3099(19)30272-5","volume":"19","author":"JM Liou","year":"2019","unstructured":"Liou JM, Chen CC, Chang CM, et al. Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial [J]. Lancet Infect Dis. 2019;19(10):1109\u201320.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"1124_CR10","doi-asserted-by":"publisher","first-page":"e13077","DOI":"10.1111\/hel.13077","volume":"29","author":"J Chen","year":"2024","unstructured":"Chen J, Zhang Y, Min H, et al. Dynamic changes in the gut microbiota after bismuth quadruple therapy and high-dose dual therapy for Helicobacter pylori eradication [J]. Helicobacter. 2024;29(2):e13077.","journal-title":"Helicobacter"},{"issue":"6","key":"1124_CR11","doi-asserted-by":"publisher","first-page":"e13017","DOI":"10.1111\/hel.13017","volume":"28","author":"NI Ismail","year":"2023","unstructured":"Ismail NI, Nawawi KNM, Hsin DCC, et al. Probiotic containing Lactobacillus reuteri DSM 17648 as an adjunct treatment for Helicobacter pylori infection: A randomized, double-blind, placebo-controlled trial [J]. Helicobacter. 2023;28(6):e13017.","journal-title":"Helicobacter"},{"key":"1124_CR12","doi-asserted-by":"crossref","unstructured":"Viazis N, Argyriou K, Kotzampassi K et al. A Four-Probiotics regimen combined with A standard Helicobacter pylori-Eradication treatment reduces side effects and increases eradication rates [J]. Nutrients, 2022, 14(3).","DOI":"10.3390\/nu14030632"},{"issue":"5","key":"1124_CR13","doi-asserted-by":"publisher","first-page":"e12529","DOI":"10.1111\/hel.12529","volume":"23","author":"AG Mcnicholl","year":"2018","unstructured":"Mcnicholl AG, Molina-Infante J, Lucendo AJ, et al. Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double-blind, placebo-controlled trial [J]. Helicobacter. 2018;23(5):e12529.","journal-title":"Helicobacter"},{"issue":"21","key":"1124_CR14","doi-asserted-by":"publisher","first-page":"11061","DOI":"10.1039\/D2FO02034C","volume":"13","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Li Z, Zhao L, et al. Two novel lactic acid bacteria, Limosilactobacillus fermentum MN-LF23 and Lactobacillus gasseri MN-LG80, inhibited Helicobacter pylori infection in C57BL\/6 mice [J]. Food Funct. 2022;13(21):11061\u20139.","journal-title":"Food Funct"},{"issue":"2","key":"1124_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF01535722","volume":"33","author":"J Svedlund","year":"1988","unstructured":"Svedlund J, Sjodin I, Dotevall G. GSRS\u2013a clinical rating scale for Gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease [J]. Dig Dis Sci. 1988;33(2):129\u201334.","journal-title":"Dig Dis Sci"},{"issue":"10","key":"1124_CR16","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","volume":"29","author":"X Wang","year":"2019","unstructured":"Wang X, Sun G, Feng T, et al. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer\u2019s disease progression [J]. Cell Res. 2019;29(10):787\u2013803.","journal-title":"Cell Res"},{"issue":"17","key":"1124_CR17","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, et al. Fastp: an ultra-fast all-in-one FASTQ preprocessor [J]. Bioinformatics. 2018;34(17):i884\u201390.","journal-title":"Bioinformatics"},{"issue":"4","key":"1124_CR18","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with bowtie 2 [J]. Nat Methods. 2012;9(4):357\u20139.","journal-title":"Nat Methods"},{"key":"1124_CR19","doi-asserted-by":"crossref","unstructured":"Beghini F, Mciver LJ, Blanco-Miguez A et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with biobakery 3 [J]. Elife, 2021, 10.","DOI":"10.7554\/eLife.65088"},{"issue":"3","key":"1124_CR20","doi-asserted-by":"publisher","first-page":"e13103","DOI":"10.1111\/hel.13103","volume":"29","author":"Y Yu","year":"2024","unstructured":"Yu Y, Xue J, Lin F, et al. Global primary antibiotic resistance rate of Helicobacter pylori in recent 10 years: A systematic review and Meta-Analysis [J]. Helicobacter. 2024;29(3):e13103.","journal-title":"Helicobacter"},{"issue":"40","key":"1124_CR21","doi-asserted-by":"publisher","first-page":"4596","DOI":"10.3748\/wjg.v24.i40.4596","volume":"24","author":"YW Zhang","year":"2018","unstructured":"Zhang YW, Hu WL, Cai Y, et al. Outcomes of furazolidone- and amoxicillin-based quadruple therapy for Helicobacter pylori infection and predictors of failed eradication [J]. World J Gastroenterol. 2018;24(40):4596\u2013605.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1124_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/gutjnl-2015-309197","volume":"65","author":"KF Pan","year":"2016","unstructured":"Pan KF, Zhang L, Gerhard M, et al. A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication [J]. Gut. 2016;65(1):9\u201318.","journal-title":"Gut"},{"issue":"3","key":"1124_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.amjmed.2005.10.003","volume":"119","author":"T Suzuki","year":"2006","unstructured":"Suzuki T, Matsuo K, Ito H, et al. Smoking increases the treatment failure for Helicobacter pylori eradication [J]. Am J Med. 2006;119(3):217\u201324.","journal-title":"Am J Med"},{"issue":"5","key":"1124_CR24","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00228-019-02625-0","volume":"75","author":"H Seddik","year":"2019","unstructured":"Seddik H, Boutallaka H, Elkoti I, et al. Saccharomyces boulardii CNCM I-745 plus sequential therapy for Helicobacter pylori infections: a randomized, open-label trial [J]. Eur J Clin Pharmacol. 2019;75(5):639\u201345.","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"1124_CR25","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/j.1440-1746.2011.06985.x","volume":"27","author":"R Deguchi","year":"2012","unstructured":"Deguchi R, Nakaminami H, Rimbara E, et al. Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy [J]. J Gastroenterol Hepatol. 2012;27(5):888\u201392.","journal-title":"J Gastroenterol Hepatol"},{"key":"1124_CR26","doi-asserted-by":"publisher","first-page":"1033063","DOI":"10.3389\/fimmu.2022.1033063","volume":"13","author":"C He","year":"2022","unstructured":"He C, Xie Y, Zhu Y, et al. Probiotics modulate Gastrointestinal microbiota after Helicobacter pylori eradication: A multicenter randomized double-blind placebo-controlled trial [J]. Front Immunol. 2022;13:1033063.","journal-title":"Front Immunol"},{"issue":"12","key":"1124_CR27","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1136\/gut.32.12.1473","volume":"32","author":"JE Crabtree","year":"1991","unstructured":"Crabtree JE, Shallcross TM, Heatley RV, et al. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis [J]. Gut. 1991;32(12):1473\u20137.","journal-title":"Gut"},{"issue":"6","key":"1124_CR28","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1136\/gut.48.6.743","volume":"48","author":"EM El-Omar","year":"2001","unstructured":"El-Omar EM. The importance of Interleukin 1beta in Helicobacter pylori associated disease [J]. Gut. 2001;48(6):743\u20137.","journal-title":"Gut"},{"key":"1124_CR29","doi-asserted-by":"publisher","first-page":"1125658","DOI":"10.3389\/fimmu.2023.1125658","volume":"14","author":"B Yu","year":"2023","unstructured":"Yu B, Xiang L, Peppelenbosch MP, et al. Overlapping cytokines in H. pylori infection and gastric cancer: A tandem meta-analysis [J]. Front Immunol. 2023;14:1125658.","journal-title":"Front Immunol"},{"key":"1124_CR30","doi-asserted-by":"publisher","first-page":"17004","DOI":"10.1038\/nmicrobiol.2017.4","volume":"2","author":"J Halfvarson","year":"2017","unstructured":"Halfvarson J, Brislawn CJ, Lamendella R, et al. Dynamics of the human gut Microbiome in inflammatory bowel disease [J]. Nat Microbiol. 2017;2:17004.","journal-title":"Nat Microbiol"},{"key":"1124_CR31","doi-asserted-by":"publisher","first-page":"107321","DOI":"10.1016\/j.phrs.2024.107321","volume":"207","author":"C Cao","year":"2024","unstructured":"Cao C, Yue S, Lu A, et al. Host-Gut microbiota metabolic interactions and their role in precision diagnosis and treatment of Gastrointestinal cancers [J]. Pharmacol Res. 2024;207:107321.","journal-title":"Pharmacol Res"},{"key":"1124_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1146\/annurev-med-042320-021020","volume":"73","author":"Y Shan","year":"2022","unstructured":"Shan Y, Lee M, Chang EB. The gut Microbiome and inflammatory bowel diseases [J]. Annu Rev Med. 2022;73:455\u201368.","journal-title":"Annu Rev Med"},{"issue":"5","key":"1124_CR33","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","volume":"71","author":"WM De Vos","year":"2022","unstructured":"De Vos WM, Tilg H, Van Hul M, et al. Gut Microbiome and health: mechanistic insights [J]. Gut. 2022;71(5):1020\u201332.","journal-title":"Gut"},{"issue":"1","key":"1124_CR34","doi-asserted-by":"publisher","first-page":"2186677","DOI":"10.1080\/19490976.2023.2186677","volume":"15","author":"A Mannion","year":"2023","unstructured":"Mannion A, Sheh A, Shen Z, et al. Shotgun metagenomics of gastric biopsies reveals compositional and functional Microbiome shifts in High- and Low-Gastric-Cancer-Risk populations from Colombia, South America [J]. Gut Microbes. 2023;15(1):2186677.","journal-title":"Gut Microbes"},{"key":"1124_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ebiom.2018.08.028","volume":"35","author":"L Chen","year":"2018","unstructured":"Chen L, Xu W, Lee A, et al. The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: an open-label, randomized clinical trial [J]. EBioMedicine. 2018;35:87\u201396.","journal-title":"EBioMedicine"},{"key":"1124_CR36","doi-asserted-by":"publisher","first-page":"881968","DOI":"10.3389\/fcimb.2022.881968","volume":"12","author":"Y Hu","year":"2022","unstructured":"Hu Y, Xu X, Ouyang YB, et al. Altered gut microbiota and Short-Chain fatty acids after Vonoprazan-Amoxicillin dual therapy for Helicobacter pylori eradication [J]. Front Cell Infect Microbiol. 2022;12:881968.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"1124_CR37","doi-asserted-by":"publisher","first-page":"e12871","DOI":"10.1111\/hel.12871","volume":"27","author":"L Wang","year":"2022","unstructured":"Wang L, Yao H, Tong T, et al. Dynamic changes in antibiotic resistance genes and gut microbiota after Helicobacter pylori eradication therapies [J]. Helicobacter. 2022;27(2):e12871.","journal-title":"Helicobacter"},{"issue":"1","key":"1124_CR38","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40121-020-00372-9","volume":"10","author":"B Tang","year":"2021","unstructured":"Tang B, Tang L, Huang C, et al. The effect of probiotics supplementation on gut microbiota after Helicobacter pylori eradication: A multicenter randomized controlled trial [J]. Infect Dis Ther. 2021;10(1):317\u201333.","journal-title":"Infect Dis Ther"},{"issue":"6","key":"1124_CR39","doi-asserted-by":"publisher","first-page":"e12856","DOI":"10.1111\/hel.12856","volume":"26","author":"C Yang","year":"2021","unstructured":"Yang C, Liang L, Lv P, et al. Effects of non-viable Lactobacillus reuteri combining with 14-day standard triple therapy on Helicobacter pylori eradication: A randomized double-blind placebo-controlled trial [J]. Helicobacter. 2021;26(6):e12856.","journal-title":"Helicobacter"},{"issue":"6","key":"1124_CR40","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1080\/19490976.2019.1589281","volume":"10","author":"YJ Jang","year":"2019","unstructured":"Jang YJ, Kim WK, Han DH, et al. Lactobacillus fermentum species ameliorate dextran sulfate sodium-induced colitis by regulating the immune response and altering gut microbiota [J]. Gut Microbes. 2019;10(6):696\u2013711.","journal-title":"Gut Microbes"},{"key":"1124_CR41","doi-asserted-by":"publisher","first-page":"109505","DOI":"10.1016\/j.jnutbio.2023.109505","volume":"124","author":"Y Liu","year":"2024","unstructured":"Liu Y, Liu G, Fang J. Progress on the mechanisms of Lactobacillus plantarum to improve intestinal barrier function in ulcerative colitis [J]. J Nutr Biochem. 2024;124:109505.","journal-title":"J Nutr Biochem"},{"key":"1124_CR42","doi-asserted-by":"crossref","unstructured":"Yao S, Zhao Z, Wang W et al. Bifidobacterium Longum: Protection against Inflammatory Bowel Disease [J]. J Immunol Res, 2021, 2021: 8030297.","DOI":"10.1155\/2021\/8030297"},{"key":"1124_CR43","doi-asserted-by":"crossref","unstructured":"Sheridan PO, Louis P, Tsompanidou E et al. Distribution, organization and expression of genes concerned with anaerobic lactate utilization in human intestinal bacteria [J]. Microb Genom, 2022, 8(1).","DOI":"10.1099\/mgen.0.000739"},{"issue":"1","key":"1124_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1907272","volume":"13","author":"MK Stoeva","year":"2021","unstructured":"Stoeva MK, Garcia-So J, Justice N, et al. Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease [J]. Gut Microbes. 2021;13(1):1\u201328.","journal-title":"Gut Microbes"}],"container-title":["Nutrition Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12937-025-01124-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12937-025-01124-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12937-025-01124-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T15:28:37Z","timestamp":1751902117000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionj.biomedcentral.com\/articles\/10.1186\/s12937-025-01124-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1124"],"URL":"https:\/\/doi.org\/10.1186\/s12937-025-01124-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5403420\/v1","asserted-by":"object"}]},"ISSN":["1475-2891"],"issn-type":[{"value":"1475-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was registered with the Chinese Clinical Trial Registry (registration number: ChiCTR220059817) and was approved by the Medical Ethics Committee of The First Medical Center of Chinese PLA General Hospital (approval number: S2022\u2013060\u201302). This study was conducted in accordance with the principles of good clinical practice and the Declaration of Helsinki. All participants voluntarily signed a written informed consent form after fully understanding the potential benefits and risks of participating in the trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All study subjects gave their written informed consent that their data could be used for publications in anonymized form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}